← Devices & Neurotechnology
Details checkedStatus confirmedHistorical/discontinuedCheckedregulatory
Oticon Medical Neuro System
Also known as: Neuro System, Neuro Zti, Neuro 2, Oticon Medical cochlear implant system
Oticon Medical / Demant
Company
Oticon Medical / Demant
Program Type
Device
Modality
Cochlear/Auditory Implant
Stage
Marketed
Status
Discontinued
Target Gene
—
Route / Mode
Implantable cochlear implant with external sound processor
Confidence
94%
Status Confidence
Status confirmed
Evidence Strength
Needs more support
Last Reviewed
2026-05-31
Geography
United States, Europe, global legacy installed base
Population
adult, pediatric, bilateral, profound
Trial IDs
0
Mechanism
A cochlear implant system centered on the Neuro Zti implant and Neuro external processor for severe-to-profound sensorineural hearing loss.
Indications
Notes
Historically important competitive cochlear implant platform. Demant decided to discontinue the hearing implants business in 2022, making Neuro a legacy platform rather than an active growth franchise.
Evidence & Sources
3 structured sourcesKey Events
Related Programs
Apple AirPods Pro Hearing Health Features
Company: Apple · Hearing Aid/Software · Marketed
Nuance Audio Hearing Aid Software
Company: EssilorLuxottica · Hearing Aid/Software · Marketed
Cochlear Nucleus Nexa System
Company: Cochlear · Cochlear/Auditory Implant · Marketed
Envoy Medical Acclaim Cochlear Implant
Company: Envoy Medical · Cochlear/Auditory Implant · Phase 2/3
MED-EL SYNCHRONY Cochlear Implant System
Company: MED-EL · Cochlear/Auditory Implant · Marketed
Phonak Audéo Sphere Infinio
Company: Phonak · Hearing Aid/Software · Marketed